Author

L. Mastracci

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Bachelot· 1 shared A. Fontaine· 1 shared B. Bellessort· 1 shared C. De Lombares· 1 shared C. Pirazzini· 1 shared E. Duvernois-Berthet· 1 shared G. Alfama· 1 shared G. Levi· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Bachelot

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Comparative analysis of molecular signatures suggests the use of gabapentin for the management of endometriosis-associated pain

B. Bellessort, A. Bachelot, V. Grouthier, C. De Lombares, N. Narboux-Neme, P. Garagnani, C. Pirazzini, S. Astigiano, L. Mastracci, A. Fontaine, G. Alfama, E. Duvernois-Berthet, G. Levi

The paper identifies CACNA2D1, CACNA2D2, and CACNA2D3 as potential targets for gabapentin in treating endometriosis-associated pain through comparative gene expression analysis.

bioRxiv · Jan 22, 2018Pharmacology & Toxicology